Monthly Archives: September 2019

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PS, CADE and TME

NEW YORK, NY / ACCESSWIRE / September 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Pluralsight, Inc. (NASDAQGS:PS)
Class Period: August 2, 2018 to July 31, 2019
Lead Plaintiff Deadline: October 15, 2019

According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering ("SPO") that it was behind schedule onboarding new sales representatives, which was hurting the Company's sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

Learn about your recoverable losses in PS: http://www.kleinstocklaw.com/pslra-1/pluralsight-inc-loss-submission-form?id=3735&from=1

Cadence Bancorporation (NYSE:CADE)
Class Period: July 23, 2018 to July 22, 2019
Lead Plaintiff Deadline: November 15, 2019

The complaint alleges that during the class period Cadence Bancorporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company's loans posed an increased risk of loss; (3) as a result, the Company was reasonably likely to incur significant losses for certain loans; (4) the Company's financial results would suffer a material adverse impact; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in CADE: http://www.kleinstocklaw.com/pslra-1/cadence-bankcorporation-loss-submission-form?id=3735&from=1

Tencent Music Entertainment Group (NYSE:TME)
Class Period: December 12, 2018 to August 26, 2019
Lead Plaintiff Deadline: November 25, 2019

During the class period, Tencent Music Entertainment Group allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Tencent Music's exclusive licensing arrangements with major record labels were anticompetitive; (2) consequently, sublicensing such content from Tencent Music was unreasonably expensive, in violation of Chinese antimonopoly laws; (3) these anticompetitive efforts were reasonably likely to lead to regulatory scrutiny; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in TME: http://www.kleinstocklaw.com/pslra-1/tencent-music-entertainment-group-loss-submission-form?id=3735&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 561280

INVESTOR DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against 3M Company and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against 3M Company ("3M" or "the Company") (NYSE:MMM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 9, 2017 and May 28, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before September 27, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. 3M held overwhelming amounts of evidence internally documenting the toxic nature of its man-made chemicals or per- and polyfluoroalkyl substances ("PFAS"). The evidence, which spanned decades, matched claims by February 2018 claims by Minnesota's Attorney General. The Company has a track record of downplaying negative information about PFAS. The Company's knowledge has created significant legal exposure for the Company at multiple levels of government related to the intentional concealment of PFAS toxicity. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about 3M, investors suffered damages.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
www.schallfirm.com
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561282

INVESTOR DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB ("Oasmia" or "the Company") (NASDAQ:OASM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between October 23, 2015 and July 9, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before September 27, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Oasmia engaged in deceptive and improper related-party transactions with Alceco International S.A. and Ardenia Investment LTD. These improper transactions resulted in millions of Swedish Kronor not accounted for in the Company's books. Other transactions related to the Company's patents were also "carried out in a doubtful way." Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Oasmia, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561281

Atlas Mara Limited Announces Notice of Results

H1 2019 Results Release Date and Conference Call Details

TORTOLA / ACCESSWIRE / September 27, 2019 / Atlas Mara Limited (LSE:ATMA) ("Atlas Mara", or "the Company"), the sub-Saharan Africa financial services group, will be holding a conference call for investors in connection with the publication of its H1 2019 Results at 12:30pm EDT / 5:30pm BST on 30 September 2019. Details for the conference call are below.

Conference Call Details:
United States: +1 (631) 913 1422
United Kingdom: +44 3333000804
Participant PIN Code: 80494960#
Date: Monday, 30 September 2019
Start time: 12:30pm EDT / 5:30pm BST

Contacts
Investors
Kojo Dufu, +1 (212) 883 4330

Media
Anthony Silverman, +44 (0)7818 036 579

About Atlas Mara

Atlas Mara Limited (LON: ATMA) is a financial services institution founded by Bob Diamond and listed on the London Stock Exchange. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, deliver excellent customer service and accelerate financial inclusion. For more information, visit www.atlasmara.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Atlas Mara

ReleaseID: 561279

BitMax.io, One of the Fastest Growing Asian-based Global Platforms

NEW YORK, NY / ACCESSWIRE / September 27, 2019 / September 11th 2019, Dr. George Cao, Co-founder & CEO of BitMax.io, sent out A Public Letter to BitMax.io (BTMX.io) Global Community, and marked a significant milestone of the platform's first year of operation. With its relentless focus, BitMax.io has been make great stride in platform build-out, customer service improvement, innovative product launch as well as quality listing across wide spectrum of blockchain industry. It has clearly established itself as emerging innovator the highly competitive digital asset trading space. Happy one-year anniversary to BitMax.io!

1. First Platform to Introduce and Discontinue "Transaction Mining & Reverse-Mining"

BitMax .io is a Singapore-registered global digital asset trading platform, founded by a group of Wall Street quant trading veterans. Over the past months, this platform has been among one of top exchanges by trading volume according to data reported by Coinmarketcap ranking service.

Initially BitMax.io stood out as the first of its kind, introducing "Transaction-Mining & Reverse-Mining" combined mechanism to the digital asset trading industry. As part of initial platform ecosystem buildout, this transaction-based mining module was introduced in November 2018 in order to attract liquidity and accelerate customer acquisition – especially during the rough market condition at the launch. This unique trading mechanism has been instrumental to the design and development of BTMX (the platform native token) economics, which many experienced traders and platform users found brilliant and efficient.

Recently BitMax.io announced to discontinue the very unique Transaction Mining & Reverse Mining program. This is another strong signal that BitMax.io is transitioning into a new phase of business expansion and next-stage strategic plan implementation.

2. New Phase of Business Expansion and Product Line-up

In the business expansion perspective, BitMax.io recently announced the launch of incubator fund JV, B-Tech and achieved strategic partnership with UltrAlpha.io asset service platform. From the product development perspective, BitMax.io introduced innovative margin trading and volatility card earlier this year, which have also been well received by the community.

Then margin trading functions allows the users to leverage their tradable asset for potential higher return on investment with proper risk management. The number of trading pairs that support margin has increased from initial less than 10 to almost 90, even including BTMX pairs. It also expands the utility functions of BTMX, and attracts the liquidity to the platform. (The margin trading function of BitMax.io is not available for North American markets.)

Similar to the margin trading, the introduction of Volatility Card again built upon the advanced expertise of BitMax.io team in financial product design, and showcased the team's deep understanding of inner working of capital market. BitMax.io Volatility Card is the first volatility-linked derivative product for users to forecast and trade off price fluctuation of underlying major coins during preset time windows in a simple yet effective way. This new type of volatility product successfully helps users to gains exposure to the increasing volatility from both trading and risk management perspectives.

3. Other Fundamental Components of BitMax.io Platform

Across the industry, BitMax.io has the lowest transaction fee among trading exchanges and platforms. Currently it charges 0.04% for both makers and takers in regular trading with a low withdrawal fee structure as well.

As a way of giving back to the community, BitMax set aside 80% of net transaction fee revenues as data usage reward for holding the BTMX token. As at the time of writing, the Annual Percentage Rate (APR) is currently ranging between 40%-50% – this can be seen as an attractive passive benefit to loyal holders of the native token. Usually, users are required to lock up their BTMX token and get rewards.

As part of ongoing enhancement, r sthe platform also has been taking steps to optimize its infrastructure from security monitoring to user experience on website and APP.

Amidst the recent market condition, BitMax.io seems to be staying on an inspiring track and working through the roadmap for its users. BitMax.io is still identified as the fastest growing Asian platform, and one of the most promising across the globe. It is well proved that the efforts by the pioneering team is pushing upward the standards of professionalism and excellence service among the industry. Looking at the trends, performance, commitment and innovations, I am very much convinced to keep BitMax.io under my watchlist.

CONTACT:
Website: https://bitmax.io
Official English Telegram: https://t.me/BitMaxioEnglishOfficial
medium: https://medium.com/bitmax-io
Reddit: https://www.reddit.com/r/BitMax/
Email: media@bitmax.io
Bella Long
+1 (917) 379-8248

SOURCE: BitMax

ReleaseID: 561271

Pea Protein Market to Trace Exponential Gain over USD 150 million by 2024

Global pea protein market size is expected to be worth over USD 150 million by 2024 due to extensive application in food & beverages sector and its use as additives to fulfill nutrition/protein needs of infants

India – September 27, 2019 /MarketersMedia/

Global pea protein market size is expected to be worth over USD 150 million by 2024 due to extensive application in food & beverages sector and its use as additives to fulfill nutrition/protein needs of infants. It provides benefits such as high iron & branched chain amino acid contents, easy digestibility, and hypoallergenic features. Lysine, valine, and isoleucine ingredients of these pea protein products help in producing muscle tissues All these factors are likely to boost the demand for these products in coming years. Pea protein industry size worth over 14.5 kilotons in 2017, is projected to register a CAGR of 12% over the period of 2018-2024. Low allergenic potential, nutritional & functional advantages, growing product awareness, clean product flavors, and cost efficiency over other equivalents are the factors predicted to propel the industry growth trends over the forecast period. However, low acceptance of protein sources, except soy can dampen the market growth in the future.

Request for a sample of this report @ https://www.graphicalresearch.com/request/1059/sample

Pea protein market is segmented in terms of applications, products, and regions.

Pea protein isolate market is forecast to grow at a rate of 12.5% over 2018-2024 in terms of volume

Pea protein concentrates market contributed about 30% of the overall market share in 2017, with predicted gains of around 11.5% over the forecast timeline in terms of volume.

Textured pea protein market is predicted to generate a revenue of over USD 17 million by 2024 owing to its growing application/use in food & beverages industry as a result of outstanding characteristics/features such as high fiber contents and meat like composition.

Pea protein isolate market, contributing over 45% of overall market share in 2017, is anticipated to dominate the application segment over the forecast timeline. It is forecast to reach over 15 kilo tons by 2024 with a growth rate over 12.5% over period of 2018-2024. These products find growing application in food & beverage industry due to its non-allergen and emulsified features.

Pea protein sports supplements market is anticipated to record a CAGR of around 12.5% over 2018-2024 in terms of volume

Pea protein meat substitutes market share, which was over 35% in 2017, is predicted to grow noticeably over the forecast timeframe as a result of changing food habits and rising demand for protein rich diet.

Pea protein sports supplements market is projected to grow at a rate of around 12.5% over the forecast timeframe with pea protein rich products like nutrition bars and snacks helping in stimulating/regulating metabolism of heart muscles.

Asia Pacific pea protein market is forecast to record highest gains of around 14.5% over 2018-2024

North America pea protein market is predicted to record over 35% of the overall revenue share in the next few years. U.S market is predicted to contribute maximum revenue share owing to rising consumer trend for health products with good taste.

Asia Pacific pea protein market is predicted to grow at a rate of around 14.5% over the forecast timeline, with China, Indonesia, Malaysia, and India contributing heavily to the regional growth. Furthermore, large vegetarian population, innovative extraction methods, and modern R&D initiatives taken by various firms are the key factors driving the regional growth.

Key industry participants include Burcon NutraScience, Cosucra Groupe Warcoing, Roquette Freres, and Nutri-Pea Limited.

Browse key industry insights along with Table of Content @ https://www.graphicalresearch.com/industry-insights/1059/pea-protein-market

Segments Covered in this Report:

Pea Protein Market By Product
Isolates
Concentrates
Textured

Pea Protein Market By Application
Meat substitutes
Nutraceuticals
Sports supplements
Others

Related Reports:

Us Organic Ice Cream Market : https://www.marketwatch.com/press-release/us-organic-ice-cream-market-to-witness-growth-more-than-45-cagr-till-2024-2019-09-24

Italy And Spain Biostimulants Market : https://www.marketwatch.com/press-release/italy-spain-biostimulants-market-size-expected-to-exceed-usd-386-mn-by-2024-2019-09-25

Germany And United States Non Alcoholic Beer Market : https://www.marketwatch.com/press-release/germany-us-non-alcoholic-beer-market-size-determine-to-rise-at-usd-63-bn-by-2024-2019-09-25

Contact Info:
Name: Parikhit B.
Email: Send Email
Organization: Graphical Research
Website: https://www.graphicalresearch.com/industry-insights/1059/pea-protein-market

Source URL: https://marketersmedia.com/pea-protein-market-to-trace-exponential-gain-over-usd-150-million-by-2024/88923548

Source: MarketersMedia

Release ID: 88923548

Elementia Announces the Sale of its U.S. Cement Assets in Pennsylvania

MEXICO CITY, MEXICO / ACCESSWIRE / September 27, 2019 / Elementia, S.A.B. de C.V. (BMV: ELEMENT*) ("the Company", or "Elementia"), announces the sale of its cement assets in Pennsylvania, United States to Lehigh Hanson, Inc., a subsidiary of HeidelbergCement for a gross value of 151 million dollars, free of cash and debt. The assets are part of Elementia's U.S. cement subsidiary Giant Cement Holding, Inc.

Proceeds from this transaction will be mainly used for debt repayment and general corporate purposes.

The transaction is subject to the approval of anti-trust authorities. The Company will inform the market once it has been received.

About Elementia

Elementia is a unique platform that manufactures and commercializes building materials for the construction industry and adds value to all stages of this industry. The Company has grown, both organically and through strategic mergers and acquisitions, consolidating operations in 9 countries in the Americas, showing strong growth in its Cement business unit, while maintaining its leadership in the Metals business, and through our Building Systems unit, we offer lightweight construction products, which is the main building trend in the market. This has been possible thanks to the passion and dedication of its more than 6,000 employees and the leadership of its main brands, including: Cementos Fortaleza®, Giant®, Keystone® and Dragon®; Nacobre®; Allura®, Mexalit®, Plycem®, Eternit®, Duralit® and Fibraforte®, among others.

INVESTOR RELATIONS

ALFONSO MOLINA

T: +52 (55) 5728 5319

www.elementia.com

amolinar@elementia.com

SOURCE: ELEMENTIA, S.A.B. DE C.V.

ReleaseID: 561276

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CAH, VAL and SRPT

NEW YORK, NY / ACCESSWIRE / September 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Cardinal Health, Inc. (NYSE:CAH)
Class Period: March 2, 2015 to May 2, 2018
Lead Plaintiff Deadline: September 30, 2019

The complaint alleges that throughout the class period Cardinal Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) following Cardinal's acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis's performance were never implemented across Cordis; 2) Cordis's antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; 3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; 4) the Company materially overstated Cordis's inventory balances; 5) Cordis was not "performing well" and its integration was not "on track," "going incredibly well" or "largely on plan"; and 6) to correct Cordis's deficiencies, the Company would have to make substantial investments in Cordis's IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

Learn about your recoverable losses in CAH: http://www.kleinstocklaw.com/pslra-1/cardinal-health-inc-loss-submission-form?id=3734&from=1

Valaris plc (NYSE:VAL)
Class Period: April 11, 2019 to July 31, 2019
Lead Plaintiff Deadline: October 21, 2019

The lawsuit alleges Valaris plc made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company's second quarter 2019 results; (iii) the merger leading to Valaris's establishment could not deliver on its touted benefits; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in VAL: http://www.kleinstocklaw.com/pslra-1/valaris-plc-loss-submission-form?id=3734&from=1

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Class Period: September 6, 2017 to August 19, 2019
Lead Plaintiff Deadline: October 29, 2019

During the class period, Sarepta Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) golodirsen, Sarepta's drug for the treatment of Duchenne muscular dystrophy, posed significant safety risks to patients; (ii) consequently, the New Drug Application package for golodirsen's accelerated approval was unlikely to receive Food and Drug Administration approval; and (iii) as a result, Sarepta's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SRPT: http://www.kleinstocklaw.com/pslra-1/sarepta-therapeutics-inc-loss-submission-form?id=3734&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 561269

Bronstein, Gewirtz & Grossman, LLC Announces Investigation Against Altria Group, Inc. (MO)

NEW YORK, NY / ACCESSWIRE / September 27, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altria Group, Inc. ("Altria" or the "Company") (NYSE:MO). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/mo.

The investigation concerns whether Altria and certain of its officers and/or directors have violated federal securities laws.

On September 24, 2019, post-market, the Financial Times reported that Philip Morris International Inc. had called off talks of a $200 billion merger with Altria likely due to increasing public and governmental scrutiny of vaping and Altria's 35% stake in industry-leading Juul Labs, Inc. ("Juul"). That same day, Juul was announced as the target of another federal investigation. Then, on September 25, 2019, media outlets reported the resignation of Juul's Chief Executive Officer and that Juul would stop all U.S. advertising.

If you are aware of any facts relating to this investigation, or purchased Altria shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/mo. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 561268

IOV Labs Brings RSK Technology to 30 Million Users Social Network by Acquiring Taringa

GIBRALTER / ACCESSWIRE / September 27, 2019 / IOV Labs, the creator of the RSK Bitcoin Smart Contract platform and the RIF token, announced today the acquisition of Taringa, the top Spanish-speaking social network in the world with 30 million users and over 1,000 active online communities.

Having access to Taringa's user base will provide the company with invaluable information and data to test and distribute new decentralized infrastructure and apps powered by the RSK platform and the RIF token at a large scale.

Jointly with Taringa's leadership, the company plans to create innovative consumer products and services for its communities, using RSK's decentralized infrastructure.

Diego Gutierrez Zaldivar, CEO of IOVLabs, commented: "Blockchain is powerful technology, but it needs mass adoption to create meaningful value. This acquisition puts us at the forefront of adoption in distributed ledger technologies. Having access to such a large community will also be invaluable for gathering quick feedback from users of all the RIF-powered tools and protocols we are launching in the near future. We see Taringa as the first step towards massive adoption of both RSK and RIF platforms, and a great step forward for our long term vision of empowering individuals through decentralization. We can't wait to share more news about the first products very soon, as we continue building the Internet of Value".

Matías Botbol, CEO of Taringa, commented: "We are very excited about joining forces with the creators of RIF and RSK, as we truly believe that our users and communities should benefit from the contributions they make to our social network. We are already building our first tool to allow Taringa users to get rewarded by being active participants in their communities. Once this is in place, we envision adding more features, including peer-to-peer token exchanges, a marketplace for other dApps to start offering products and services to our users, and more. Our ultimate goal is to create a new open, decentralized Internet that respects individual's freedom of speech and privacy".

IOV Labs has been forging partnerships and developing decentralized infrastructure and products since the launch of the RSK mainnet in January 2018 and the release of the RIF Token in November 2018. The company, headquartered in Gibraltar, has a global footprint with offices in Buenos Aires, Montevideo, Shanghai, Singapore, and an innovation studio in San Francisco.

For press inquiries: press@iovlabs.org

About IOV Labs

IOV Labs is a purpose driven organization focused on developing the platforms needed for a new blockchain-based financial system that will enable worldwide financial inclusion and bridge the gap between these nascent technologies and mass adoption.

The organization currently develops the most popular implementations of the RSK Smart Contract Network and RIF OS platforms. RSK Network is the most secure Smart Contract platform in the world, as it relies on Bitcoin's hash power. RIF OS protocols, are a suite of open and decentralized infrastructure protocols that enable faster, easier and scalable development of distributed applications (dApps) within a unified environment to enable mass adoption of Bitcoin and RSK.

About Taringa

Taringa! is the most visited entertainment and knowledge site in Latin America and Spain with a broad range of content, where users share information, news, videos and links. With more than 30 million registered members , and 1000 active communities and over 13 million active users monthly Taringa! generates more than 8 million shares daily, and is the largest social media network in Spanish speaking countries.

SOURCE: IOV Labs

ReleaseID: 561258